Publications by authors named "Theodore Reiss"

Claim this Profile
D
Design of RESOLVE Lung, a multinational Phase 2, randomized, placebo-controlled trial of the anti-GM-CSF monoclonal antibody namilumab in patients with chronic pulmonary sarcoidosis.
Bernt van den Blink, Chantal M Petit, Hayes M Dansky, Min Lin, Marlies S Wijsenbeek-Lourens, Theodore F Reiss

Contemp Clin Trials· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Study protocol: A comparison of mobile and clinic-based spirometry for capturing the treatment effect in moderate asthma.
Elena S Izmailova, Rachel Kilian, Jessie P Bakker, Shawna Evans, Anthony D Scotina, Theodore F Reiss

Clin Transl Sci· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to "Wearable Remote Monitoring and COVID-19".
Elena S Izmailova, Theodore F Reiss

Clin Transl Sci· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CC-90001, a c-Jun N-terminal kinase (JNK) inhibitor, in patients with pulmonary fibrosis: design of a phase 2, randomised, placebo-controlled trial.
Zoran Popmihajlov, Donna J Sutherland, Gerald S Horan, Atalanta Ghosh, David A Lynch, Theodore F Reiss

BMJ Open Respir Res· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Closer to the patient means better decisions: wearable remote monitoring of patients with COVID-19 lung disease.
Elena S Izmailova, Theodore F Reiss

Clin Transl Sci· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot Study of Peak Plasma Concentration After High-Dose Oral Montelukast in Children With Acute Asthma Exacerbations.
Donald H Arnold, Sara L Van Driest, Theodore F Reiss, Jennifer C King, Wendell S Akers

J Clin Pharmacol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events associated with weight-based, high-dose montelukast exposures in children.
Donald H Arnold, Nena Bowman, Theodore F Reiss, Tina V Hartert, Wendell S Akers

Clin Toxicol (Phila)· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adverse events are rare after single-dose montelukast exposures in children.
Donald H Arnold, Nena Bowman, Theodore F Reiss, Tina V Hartert, Donna L Seger

Clin Toxicol (Phila)· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of asthma following severe respiratory syncytial virus (RSV) bronchiolitis in early childhood.
Susan Lu, Tina V Hartert, Mark L Everard, Hilde Giezek, Linda Nelsen, Theodore F Reiss

Pediatr Pulmonol· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Official American Thoracic Society Research Statement: Implementation Science in Pulmonary, Critical Care, and Sleep Medicine.
Curtis H Weiss, Jerry A Krishnan, David H Au, Bruce G Bender, Shannon S Carson, Theodore F Reiss

Am J Respir Crit Care Med· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BEAR Cage: Mentoring through Engagement.
Theodore F Reiss, Joel Moss, Timothy R Watkins, Atul Malhotra

Am J Respir Crit Care Med· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Drug development for airway diseases: looking forward.
Stephen Holgate, Alvar Agusti, Robert M Strieter, Gary P Anderson, Robert Fogel, Theodore F Reiss

Nat Rev Drug Discov· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The asthma disease activity score: a discriminating, responsive measure predicts future asthma attacks.
Steven Greenberg, Nancy Liu, Amarjot Kaur, Mani Lakshminarayanan, Yijie Zhou, Theodore F Reiss

J Allergy Clin Immunol· November 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Airway obstruction lability helps distinguish levels of disease activity in asthma.
Steven Greenberg, Nancy Liu, Amarjot Kaur, Mani Lakshminarayanan, Yijie Zhou, Theodore F Reiss

Respir Med· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collaborative science and the American Thoracic Society: cooperation in harmony with conflict of interest.
Theodore F Reiss, Joel Moss, Molly Osborne, J Randall Curtis, Nicholas S Hill

Am J Respir Crit Care Med· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and tolerability of MK-0633, a 5-lipoxygenase inhibitor, in chronic asthma.
Yasmine S Wasfi, César Villarán, Celine Le Bailly de Tilleghem, Steven S Smugar, William D Hanley, Theodore F Reiss

Respir Med· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The efficacy and tolerability of inhaled montelukast plus inhaled mometasone compared with mometasone alone in patients with chronic asthma.
George Philip, César Villarán, Shailen R Shah, Kristel Vandormael, Steven S Smugar, Theodore F Reiss

J Asthma· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Intermittent or daily montelukast versus placebo for episodic asthma in children.
Erkka Valovirta, Maria L Boza, Colin F Robertson, Nadia Verbruggen, Steven S Smugar, Theodore F Reiss

Ann Allergy Asthma Immunol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MK-0633, a potent 5-lipoxygenase inhibitor, in chronic obstructive pulmonary disease.
Jonathan A Bernstein, Nancy Liu, Barbara A Knorr, Steven S Smugar, William D Hanley, Theodore F Reiss

Respir Med· March 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase I randomized, placebo-controlled, dose-exploration study of single-dose inhaled montelukast in patients with chronic asthma.
George Philip, Andrew Pedinoff, Kristel Vandormael, Yevgen Tymofyeyev, Steven S Smugar, Theodore F Reiss

J Asthma· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A multicenter, double-blind, randomized, placebo controlled trial of a neurokinin-1 receptor antagonist for overactive bladder.
Tara L Frenkl, Haiyuan Zhu, Theodore Reiss, Olga Seltzer, Elizabeth Rosenberg

J Urol· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized placebo-controlled study of intravenous montelukast for the treatment of acute asthma.
Carlos A Camargo, Deborah M Gurner, Howard A Smithline, Rocio Chapela, Leonardo M Fabbri, Theodore F Reiss

J Allergy Clin Immunol· February 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis.
Susan Lu, Marie-Pierre Malice, S Balachandra Dass, Theodore F Reiss

J Asthma· November 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of behavior-related adverse experiences in clinical trials of montelukast.
George Philip, Carolyn M Hustad, Marie-Pierre Malice, Gertrude Noonan, Alan Ezekowitz, Theodore F Reiss

J Allergy Clin Immunol· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis